• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Human Genome Sciences - Articles and news items

GlaxoSmithKline logo

GSK completes acquisition of Human Genome Sciences

Industry news, News / 3 August 2012 / GlaxoSmithKline

GlaxoSmithKline has completed its acquisition of Human Genome Sciences for US$3.6 billion…

GlaxoSmithKline logo

GSK announces acquisition of 79% of Human Genome Sciences shares

Industry news, News / 30 July 2012 / GlaxoSmithKline

GSK announced the results of its initial tender offer for all outstanding shares of HGS…

GlaxoSmithKline logo

GSK to acquire Human Genome Sciences for US$14.25 per share in cash

Industry news, News / 16 July 2012 / GlaxoSmithKline

GSK to acquire full ownership of BENLYSTA®, albiglutide and darapladib…

GlaxoSmithKline logo

GSK sets 20 July for expiration of tender offer to acquire Human Genome Sciences

Industry news, News / 29 June 2012 / GlaxoSmithKline

Expiration is after HGS process bid deadline of 16 July…

GlaxoSmithKline logo

GSK continues with tender offer to acquire all outstanding shares of Human Genome Sciences

Industry news, News / 15 June 2012 / GlaxoSmithKline

GSK has received a renewed invitation from Human Genome Sciences’…

GlaxoSmithKline logo

GSK extends tender offer for all outstanding shares of Human Genome Sciences

Industry news, News / 8 June 2012 / GlaxoSmithKline

GSK has extended its tender offer to acquire all of the outstanding shares of HGS…

GlaxoSmithKline logo

GSK announces expiration of Hart-Scott-Rodino waiting period for tender offer for HGS

Industry news, News / 1 June 2012 / GlaxoSmithKline

GSK has clearance under the U.S. anti-trust laws to acquire HGS…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +